Choice Pharma is an international contract research organization. Though the company was originally established in the UK in 1998, Choice Pharma’s expertise is currently focused on the management of clinical trials across the Asia-Pacific region.
With 9 operational offices across the region, Choice Pharma is one of the fastest-growing CROs in Asia-Pacific. Moreover, as part of the ChoiceOne group, we also have global business support and project management capabilities based in USA, UK, Switzerland and Dubai.
Our expert team includes pharmaceutical industry specialists and authority regulators as well as experienced clinical researchers and data analysts. This spectrum of experience gives Choice Pharma a comprehensive understanding not simply of clinical trials management, but of international product development in its wider context.
From our operational bases across the Asia-Pacific region, Choice Pharma is ideally placed to access extensive patient populations, including elderly and treatment-naïve individuals. In addition, our teams maintain close working relationships with leading KOLs and major hospitals across the region.
When it comes to study management, quality and reliability are critical to everything we do. From site selection & patient recruitment, through project management & monitoring to data analysis, our entire business model is built around rigorous adherence to the principles of good clinical practice – without compromise.
Choice Pharma: commitment to excellence
There are certainly many benefits of conducting clinical trials in Asia, but realising these advantages demands uncompromising standards of trial management
Chris Wang, Managing Director